Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Prostate Adenocarcinoma”

314 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 314 results

Testing effectiveness (Phase 2)Ended earlyNCT00103376
What this trial is testing

Bortezomib With or Without Hormone Therapy in Treating Patients With Relapsed Prostate Cancer

Who this might be right for
Prostate Cancer
Medical University of South Carolina 23
Testing effectiveness (Phase 2)Study completedNCT00589420
What this trial is testing

Sorafenib and Docetaxel in Patients With Prostate Cancer That Did Not Respond to Previous Hormone Therapy

Who this might be right for
Prostate Cancer
Abramson Cancer Center at Penn Medicine 18
Testing effectiveness (Phase 2)Ended earlyNCT00176631
What this trial is testing

Licorice Root Extract and Docetaxel in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy

Who this might be right for
Prostate Cancer
Rutgers, The State University of New Jersey 10
Testing effectiveness (Phase 2)Looking for participantsNCT07410494
What this trial is testing

Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors

Who this might be right for
CancerBreast CancerNon-Small Cell Lung Cancer (NSCLC)+10 more
Essen Biotech 85
Early research (Phase 1)Study completedNCT00003439
What this trial is testing

Interleukin-12 in Treating Patients With Refractory Advanced-Stage Ovarian Cancer or Abdominal Cancer

Who this might be right for
Cancer
National Cancer Institute (NCI) 36
Early research (Phase 1)Study completedNCT00005627
What this trial is testing

Estramustine, Docetaxel, and Carboplatin in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy

Who this might be right for
Prostate Cancer
Dana-Farber Cancer Institute
Testing effectiveness (Phase 2)Study completedNCT00309894
What this trial is testing

Ketoconazole, Hydrocortisone, and GM-CSF in Treating Patients With Progressive Prostate Cancer After Hormone Therapy

Who this might be right for
Prostate Cancer
University of California, San Francisco 49
Testing effectiveness (Phase 2)Study completedNCT01051570
What this trial is testing

Carboplatin, Everolimus, and Prednisone in Treating Patients With Metastatic Prostate Cancer That Progressed After Docetaxel

Who this might be right for
Prostate Cancer
Barbara Ann Karmanos Cancer Institute 26
Testing effectiveness (Phase 2)Study completedNCT00170157
What this trial is testing

Hormone Therapy and Ipilimumab in Treating Patients With Advanced Prostate Cancer

Who this might be right for
Prostate AdenocarcinomaProstate CarcinomaRecurrent Prostate Carcinoma+2 more
Mayo Clinic 112
Testing effectiveness (Phase 2)Study completedNCT00080899
What this trial is testing

Fenretinide in Treating Patients With Biochemically Recurrent Hormone-Naïve Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateRecurrent Prostate Cancer
National Cancer Institute (NCI) 23
Early research (Phase 1)Ended earlyNCT00788307
What this trial is testing

Gene Therapy and Radioactive Iodine in Treating Patients With Locally Recurrent Prostate Cancer That Did Not Respond to External-Beam Radiation Therapy

Who this might be right for
Prostate Cancer
Mayo Clinic 8
Testing effectiveness (Phase 2)Study completedNCT00331344
What this trial is testing

Treating Patients With Metastatic Prostate Cancer Not Responding to Hormone and Chemotherapy

Who this might be right for
Adenocarcinoma of the ProstateRecurrent Prostate CancerStage IV Prostate Cancer
National Cancer Institute (NCI) 100
Testing effectiveness (Phase 2)Ended earlyNCT00471718
What this trial is testing

ABT-751 in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy

Who this might be right for
Prostate Cancer
Vanderbilt-Ingram Cancer Center 27
Testing effectiveness (Phase 2)Active Not RecruitingNCT04190446
What this trial is testing

Evaluate Hypofractionated Proton Therapy Or IMRT For Recurrent, Oligometastatic Prostate Cancer

Who this might be right for
Metastatic Prostate AdenocarcinomaOligometastatic Prostate CarcinomaProstate Adenocarcinoma+2 more
Mayo Clinic 84
Large-scale testing (Phase 3)Study completedNCT00003232
What this trial is testing

Combination Chemotherapy in Treating Pain in Hormone Refractory Metastatic Prostate Cancer

Who this might be right for
PainProstate CancerQuality of Life
NCIC Clinical Trials Group 227
Testing effectiveness (Phase 2)Study completedNCT00554918
What this trial is testing

Docetaxel and Prednisolone With or Without Zoledronic Acid and/or Strontium Chloride Sr 89 in Treating Patients With Prostate Cancer Metastatic to Bone That Has Not Responded to Hormone Therapy

Who this might be right for
Metastatic CancerProstate Cancer
University Hospital Birmingham 300
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Testing effectiveness (Phase 2)Study completedNCT01787331
What this trial is testing

Itraconazole in Treating Patients With Biochemically Relapsed Prostate Cancer

Who this might be right for
Prostate AdenocarcinomaRecurrent Prostate CarcinomaStage I Prostate Adenocarcinoma AJCC v7+2 more
University of California, San Francisco 21
Not applicableStudy completedNCT01664130
What this trial is testing

High-Dose Stereotactic Radiation for Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateRecurrent Prostate CancerStage I Prostate Cancer+3 more
Case Comprehensive Cancer Center 35
Early research (Phase 1)Study completedNCT00101972
What this trial is testing

RAV12 in Treating Patients With Metastatic or Recurrent Adenocarcinoma

Who this might be right for
Cancer
MacroGenics 53
Load More Results